Successful treatment of hidradenitis suppurativa and Crohn's disease with combined guselkumab and apremilast

被引：7

作者：

Agud-Dios, Manuel ^{[1
]}

Arroyo-Andres, Jorge ^{[1
]}

Rubio-Muniz, Carmen ^{[1
]}

Postigo-Lorente, Concepcion ^{[1
]}

机构：

[1] Hosp Univ 12 Octubre, Dept Dermatol, Madrid, Spain

来源：

DERMATOLOGIC THERAPY | 2022年 / 35卷 / 10期

关键词：

D O I：

10.1111/dth.15743

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页数：2

共 9 条

[1]

Bassas-Vila J, 2016, Actas Dermosifiliogr, V107 Suppl 2, P27, DOI 10.1016/S0001-7310(17)30006-6

[2] Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn's disease [J].

Berman, Hannah S. ;

Villa, Natalie M. ;

Shi, Vivian Y. ;

Hsiao, Jennifer L. .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (02) :261-263

[3] Treatment of severe hidradenitis Suppurativa and Fistulizing Crohn's disease with Guselkumab [J].

Croitoru, D. O. ;

Seigel, K. ;

Nathanielsz, N. ;

Elsawi, R. ;

Silverberg, M. S. ;

Piguet, V. ;

Sibbald, C. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (07) :E563-E565

[4] Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease: Report and systematic literature review of effectiveness and safety [J].

Jorgensen, Astrid-Helene Ravn ;

Holm, Jesper Gronlund ;

Thomsen, Simon Francis .

CLINICAL CASE REPORTS, 2020, 8 (12) :2873-2876

[5] Clinical, microbiological, immunological and imaging characteristics of tunnels and fistulas in hidradenitis suppurativa and Crohn's disease [J].

Jorgensen, Astrid-Helene Ravn ;

Thomsen, Simon Francis ;

Karmisholt, Katrine Elisabeth ;

Ring, Hans Christian .

EXPERIMENTAL DERMATOLOGY, 2020, 29 (02) :118-123

[6] Pharmacological development in hidradenitis suppurativa [J].

Matusiak, Lukasz ;

Jemec, Gregor B. E. ;

Szepietowski, Jacek C. .

CURRENT OPINION IN PHARMACOLOGY, 2019, 46 :65-72

[7] The use of guselkumab 100 mg every 4 weeks on patients with hidradenitis suppurativa and a literature review [J].

Montero-Vilchez, Trinidad ;

Martinez-Lopez, Antonio ;

Salvador-Rodriguez, Luis ;

Arias-Santiago, Salvador ;

Molina-Leyva, Alejandro .

DERMATOLOGIC THERAPY, 2020, 33 (03)

[8] Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study [J].

Sandborn, William J. ;

D'Haens, Geert R. ;

Reinisch, Walter ;

Panes, Julian ;

Chan, Daphne ;

Gonzalez, Susana ;

Weisel, Kathleen ;

Germinaro, Matthew ;

Frustaci, Mary Ellen ;

Yang, Zijiang ;

Adedokun, Omoniyi J. ;

Han, Chenglong ;

Panaccione, Remo ;

Hisamatsu, Tadakazu ;

Danese, Silvio ;

Rubin, David T. ;

Sands, Bruce E. ;

Afzali, Anita ;

Andrews, Jane M. ;

Feagan, Brian G. .

GASTROENTEROLOGY, 2022, 162 (06) :1650-+

[9] Apremilast for moderate hidradenitis suppurativa: Results of a randomized controlled trial [J].

Vossen, Allard R. J. V. ;

van Doorn, Martijn B. A. ;

van der Zee, Hessel H. ;

Prens, Errol P. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (01) :80-88

← 1 →